-
ATXI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Avenue Therapeutics (ATXI)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.60 mm | 2.60 mm | 2.60 mm | 2.60 mm | 2.60 mm | 2.60 mm |
Cash burn (monthly) | 774.00 k | (no burn) | 1.05 mm | 983.83 k | 963.00 k | 882.17 k |
Cash used (since last report) | 3.92 mm | n/a | 5.33 mm | 4.98 mm | 4.88 mm | 4.47 mm |
Cash remaining | -1.32 mm | n/a | -2.73 mm | -2.39 mm | -2.28 mm | -1.87 mm |
Runway (months of cash) | -1.7 | n/a | -2.6 | -2.4 | -2.4 | -2.1 |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 1 |
Closed positions | 7 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 29.88 mm |
Total shares | 4.04 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
FBIO Fortress Biotech | 3.56 mm | $469.00 k |
CVI Investments | 251.01 k | $0.00 |
Intracoastal Capital | 216.79 k | $616.00 k |
Moss Adams Wealth Advisors | 11.00 k | $27.39 mm |
WFC Wells Fargo & Company | 561.00 | $1.40 mm |
InvaGen Pharmaceuticals | 10.00 | $0.00 |
JPM JPMorgan Chase & Co. | 1.00 | $3.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Dec 24 | Neil Herskowitz | COMMON STOCK, PAR VALUE $0.0001 | Sell | Dispose S | No | No | 2 | 23 | 46.00 | 97 |
5 Nov 24 | Kranzler Jay D | COMMON STOCK, PAR VALUE $0.0001 | Sell | Dispose S | No | No | 2.24 | 61 | 136.64 | 559 |
30 Sep 24 | Kranzler Jay D | COMMON STOCK, PAR VALUE $0.0001 | Buy | Acquire P | No | No | 2.5 | 497 | 1.24 k | 620 |
27 Sep 24 | Kranzler Jay D | COMMON STOCK, PAR VALUE $0.0001 | Buy | Acquire P | No | No | 2.4 | 3 | 7.20 | 123 |
23 Sep 24 | Faith L. Charles | Employee stock option Common Stock | Grant | Acquire A | No | No | 2.46 | 30,000 | 73.80 k | 30,000 |